A Scripps Research team found that a new therapeutic that targets the kappa opioid receptor in the brain may reduce alcohol dependence. https://www.nature.com/articles/s41598-024-56500-9

This study investigates whether mifepristone, a glucocorticoid receptor antagonist, can reduce innate anxiety-like behaviors in genetically-selected Marchigian Sardinian (msP) rats.

Researchers explore how blocking specific stress-related receptors can reduce alcohol consumption in both everyday and genetically predisposed rats, paving the way for potential new treatments for alcohol use disorder.

A Scripps Research team found that a new therapeutic that targets the kappa opioid receptor in the brain may reduce alcohol dependence.

Researchers explore how blocking specific stress-related receptors can reduce alcohol consumption in both everyday and genetically predisposed rats, paving the way for potential new treatments for alcohol use disorder.

This study investigates whether mifepristone, a glucocorticoid receptor antagonist, can reduce innate anxiety-like behaviors in genetically-selected Marchigian Sardinian (msP) rats.